NF-Kb inhibition in glioblastoma: in vitro and in vivo effects of DHMEQ in tumor c...
| Grant number: | 13/23239-9 |
| Support type: | Scholarships in Brazil - Scientific Initiation |
| Effective date (Start): | April 01, 2014 |
| Effective date (End): | December 31, 2014 |
| Field of knowledge: | Biological Sciences - Genetics |
| Principal Investigator: | María Sol Brassesco Annichini |
| Grantee: | Gabriela Molinari Roberto |
| Home Institution: | Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto (FFCLRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil |
Abstract Glioblastoma represents 50% of the brain tumor in adults; being less frequent in children (9%). Despite the therapeutic advances, the median survival of glioblastoma patients is still dismal, around one year. Treatment of this tumor is generally hampered by its invasive nature that leads to a high rate of recurrence after surgery, and its resistance to apoptosis and to conventional drugs. The transcription factor AP-1 is an important point of convergence of many pathways including proliferation, apoptosis and invasion. In glioblastomas, the c-Jun subunit of AP-1 is found hyperphosphorylated and therefore more active to act on gene transcription. In this situation, c-Jun develops an important role increasing the expression of several genes involved on cell proliferation, apoptosis and tumor invasion. Recently, a new specific AP-1 inhibitor called DTCM-g was synthesized. This inhibitor blocks the phosphorylation of c-Jun, preventing its translocation into the nucleus. DTCM-g has already shown antitumor activity in osteosarcoma and bladder cancer, however its potential antiproliferative effects in glioblastoma are still unknown. In view of this, this project aims to study the influence of AP-1 inhibition by DTCM-g on tumor growth and invasion in adult and pediatric glioblastoma cell lines, based on functional tests and on the expression dinamics of genes under its regulation. | |